Successful treatment of fungal meningitis and arachnoiditis with IV voriconazole in chronic granulomatous disease (CGD)  by Belani, Kiran
2S52 International Journal of Infectious Diseases / Volume 6, Supplement 2,2002 
We report a case of RCZ caused by Rhizopus arrhizus 
(oryzae in an 84-year-old woman with poorly controlled 
diabetes. She presented with a right-sided facial droop 
of short origin, being generally unwell and ‘off legs’ over 
2 weeks with reduced appetite. Initial non-conclusive CT 
scans and late in disease appearance of key markers 
of RCZ were probably factors permitting mycosis to 
rapidly progress in its course. Despite an intensive anti- 
fungal therapy with AmBisome and Insulin sliding scale, 
patient rapidly succumbed within 4 days of presenting. 
Fine needle aspiration cytology has been suggested 
as a possible, less invasive, easier and equally effective 
alternative to pre op biopsy. The key to successful 
reduction in morbidity and mortality associated with 
this rapidly fatal disease is increasing awareness of the 
disease, an early diagnosis, correction of underlying 
metabolic derangement, prompt intensive antifungal 
therapy with amphotericin B and radical surgical 
debridement of the necrotic tissue. 
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Four year old black male with chronic granulomatous 
disease (CGD) diagnosed at 3 years and on treatment 
with Gamma Interferon and TMP/SMX presents with 
chronic bilateral pneumonia unresponsive to antibiotics. 
Bilateral lobectomy is done for Aspergillus fumigatus 
pneumonia and Rx with IV amphotericin for 4 months. 
Persistent headache lead to diagnosis of intracerebral 
hemorrhage requiring craniotomy and resection of R 
frontal mycotic aneurysm negative on fungal culture. On 
continued amphotericin therapy, 4 weeks later has 
intermittent sharp shooting pain in lower extremity and 
meningismus. Lumbar puncture reveals cerebrospinal 
fluid (CSF) polymorphonuclear pleocytosis, low glucose, 
elevated protein and negative fungal, bacterial and viral 
cultures. MRI spine has abnormal enhancement along 
the entire spinal cord and increased intensity in patchy 
areas in the conus medullaris and mid thoracic region. 
MRI brain shows meningeal enhancement and ventri- 
cular enlargement. Multiple craniotomy procedures were 
done to decompress the ventricles with ventriculostomy, 
Rickham reservoir and finally a ventriculoperitoneal 
shunt. Laminectomy and biopsy of spinal cord patchy 
lesions show inflammation with branching hyphae and 
yeast forms with negative cultures of tissue obtained. 
PCR was done. One CSF sample was positive for 
Trichosporon beiglii with multiple negative cultures. 
Steroid Rx started for increasing intracranial pressure 
(ICP), seizures and CSF protein on amphotericin and 
itraconazole Rx. Due to lack of clinical response anti- 
fungal Rx was changed to voriconazole (3mg/kg/dose 
BID X 12 weeks IV) provided by Pfizer (compassionate 
protocol). Patient is on oral voriconazole maintainence 
Rx for past 15 months with no steroids. He is seizure 
free, has a normal neurological examination with no 
adverse events during voriconazole therapy. Follow up 
MRI spine at 18 months shows no new areas of patchy 
lesion with resolution of previous abnormalities except 
for residual scarring. Serial MRI pictures during disease 
process will be displayed. 
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Background: Adherence of Candida albicans to host 
constituents, including endothelial cells and the base- 
ment membrane, is a critical early step in the patho- 
genesis of disseminated candidiasis. Recently, members 
of the C. albicans ALS (Aglutinin-Like-Sequence) 
gene family have been implicated as candidal adhesins. 
When the C. albicans ALS.5 gene is expressed in the 
normally non-adherent Saccharomyces cerevisiae, it 
renders this organism adherent to host constituents such 
as fibronectin. Two other members of the ALS gene 
family (ALS6 and ALS7) share considerable homology 
with AL%, but their function remains unknown. 
Purpose: To clone the C. albicans ALS6 and ALS7 gene 
and determine the role of their gene products in both 
adherence to host constituents and virulence in the 
mouse model of disseminated candidiasis. 
Methods: The coding sequence of ALSS, ALS6 and 
ALS7 were cloned using high fidelity PCR, placed under 
the control of the constitutive ADHl promotor and 
expressed in S. cerevisiae. Adherence of these strains to 
fibronectin was then tested using a magnetic bead assay. 
Using a PCR based disruption strategy, homozygous C. 
albicans null mutants of AL,!% and ALS7 were 
constructed, and the virulence of these strains was tested 
in the mouse model of disseminated candidiasis. 
Results: In contrast to AL%, heterologous expression 
of ALS6 and ALS7 in S. cerevisiae did not enhance 
adherence to fibronectin-coated beads. To further 
localize the area responsible for mediating binding to 
fibronectin, we constructed chimeric genes consisting of 
the N-terminal region of ALSS fused to the C-terminus 
of ALS6 (5N6C) and the ALS6 N-terminus fused to the 
ALSS C-terminus (6N5C). Expression of these con- 
structs in S cerevisiae resulted in enhanced adherence 
to fibronectin only in the strain expressing 5N6C. 
Consistent with these results, C. albicans ALS6 and 
ALS7 null mutants demonstrated normal virulence in 
the mouse model of disseminated candidiasis. 
